Natco Pharma allots 1,70,58,082 equity shares in Rights Issue at ₹750 each
Natco Pharma Ltd · Pharmaceuticals & Biotechnology
What the filing says
- Allotment of 1,70,58,082 equity shares at ₹750 per share approved on October 23, 2026
- Paid-up equity share capital increased from ₹35,82,19,740 (17,91,09,870 shares) to ₹39,23,35,904 (19,61,67,952 shares)
- Fund Raising Committee meeting held from 8.30 p.m. to 8.55 p.m. on October 23, 2026, approved the allotment
Why it's rated notable: The filing states no aggregate amount, but 1,70,58,082 shares at ₹750 come to about ₹1,279 crore, which is above the ₹500 crore fundraise floor for at least medium, and the allotment is completed.
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Allotment
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Natco Pharma Ltd
- Board / shareholder meeting outcomeMajor developmentNatco Pharma Limited announces results of 43rd AGM held on 30 September 2026
- Fundraise / allotmentNotableNATCO Pharma Limited files Letter of Offer for Rights Issue closing Oct 22, 2026
- Fundraise / allotmentNotableNatco Pharma board approves rights issue of up to ₹12,79,35,61,500
- Fundraise / allotmentNotableNatco Pharma approves rights issue of up to ₹12,79,35,61,500 via 1,70,58,082 shares
- Fundraise / allotmentNotableNatco Pharma approves rights issue up to ₹1,300 crore, updates scheme of arrangement
Other fundraise / allotment filings this fortnight
- Regency Fincorp reports Q2 & H1 FY27 results with AUM crossing ₹600 crore
- Raymond Realty Limited receives in-principle approval for preferential issue of shares
- OnEMI Technology Solutions allots 2,64,93,882 equity shares via preferential issue
- Capital Infra Trust submits post-Institutional Placement unit holding pattern
- Capital Infra Trust raises ₹1,115 crore via QIP for acquiring six HAM road assets
- Paisalo Digital Limited approves Q2 and H1 FY2026-27 unaudited financial results
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.